WO2012168949A3 - A process for preparation of nevirapine - Google Patents
A process for preparation of nevirapine Download PDFInfo
- Publication number
- WO2012168949A3 WO2012168949A3 PCT/IN2012/000393 IN2012000393W WO2012168949A3 WO 2012168949 A3 WO2012168949 A3 WO 2012168949A3 IN 2012000393 W IN2012000393 W IN 2012000393W WO 2012168949 A3 WO2012168949 A3 WO 2012168949A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nevirapine
- preparation
- chloro
- bicarbonates
- cyclization
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
The present invention provides a process for the preparation of nevirapine, which comprises reaction of 2-chloro-N-(2-chloro-4-methyl-3-pyridinyl)-3-pyridine carboxamide with cyclopropyl amine in presence of a suitable reagent such as carbonates, bicarbonates, acetates of alkali metals and lanthanum oxide, followed by cyclization of the resultant product.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1913CH2011 | 2011-06-06 | ||
IN1913/CHE/2011 | 2011-06-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012168949A2 WO2012168949A2 (en) | 2012-12-13 |
WO2012168949A3 true WO2012168949A3 (en) | 2013-03-28 |
Family
ID=47296549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2012/000393 WO2012168949A2 (en) | 2011-06-06 | 2012-06-05 | A process for preparation of nevirapine |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012168949A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106938981A (en) * | 2016-11-10 | 2017-07-11 | 浙江华海药业股份有限公司 | A kind of preparation method of NVP intermediate sphaerocrystal |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366972A (en) * | 1989-04-20 | 1994-11-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection |
US5569760A (en) * | 1994-02-03 | 1996-10-29 | Boehringer Ingelheim Kg | Process for preparing nevirapine |
US20040002603A1 (en) * | 2002-06-28 | 2004-01-01 | Boehringer Ingelheim Chemicals, Inc. | Method for making nevirapine |
WO2007010352A1 (en) * | 2005-07-19 | 2007-01-25 | Emcure Pharmaceuticals Limited | An improved process for industrial manufacture of nevirapine |
WO2008142528A2 (en) * | 2007-05-22 | 2008-11-27 | Aurobindo Pharma Limited | An improved process for preparing nevirapine |
CN101585836A (en) * | 2008-05-25 | 2009-11-25 | 浙江华海药业股份有限公司 | Novel method for preparing Nevirapine |
-
2012
- 2012-06-05 WO PCT/IN2012/000393 patent/WO2012168949A2/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366972A (en) * | 1989-04-20 | 1994-11-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection |
US5569760A (en) * | 1994-02-03 | 1996-10-29 | Boehringer Ingelheim Kg | Process for preparing nevirapine |
US20040002603A1 (en) * | 2002-06-28 | 2004-01-01 | Boehringer Ingelheim Chemicals, Inc. | Method for making nevirapine |
US6680383B1 (en) * | 2002-06-28 | 2004-01-20 | Boehringer Ingelheim Chemicals, Inc. | Method for making nevirapine |
WO2007010352A1 (en) * | 2005-07-19 | 2007-01-25 | Emcure Pharmaceuticals Limited | An improved process for industrial manufacture of nevirapine |
WO2008142528A2 (en) * | 2007-05-22 | 2008-11-27 | Aurobindo Pharma Limited | An improved process for preparing nevirapine |
CN101585836A (en) * | 2008-05-25 | 2009-11-25 | 浙江华海药业股份有限公司 | Novel method for preparing Nevirapine |
Also Published As
Publication number | Publication date |
---|---|
WO2012168949A2 (en) | 2012-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL261991B (en) | System, method and capsules for producing sparkling drinks | |
ZA201403329B (en) | Improved process for the manufacture of an alcoholic beverage and products produced by such process | |
EP2530179A4 (en) | High-strength cold-rolled steel sheet, and process for production thereof | |
ZA201307339B (en) | Steel sheets for hot stamping,use, method of production of same, and method of production of high-strength parts. | |
HUE056388T2 (en) | Carrier and capsule for the preparation of a beverage by centrifugation, assembly and process for the preparation of a beverage by centrifugation | |
PT2764126T (en) | Biosurfactants produced by a novel strain of bacillus subitilis, compositions containing them, process for obtaining and use | |
WO2013121436A3 (en) | A process for preparation of rivaroxaban and intermediates thereof | |
EP2824195A4 (en) | Process for producing press-formed product, and press-formed product | |
WO2013098833A3 (en) | Processes and intermediates for preparing rivaroxaban | |
EP2744815A4 (en) | Hydrogenation and dehydrogenation catalyst, and methods of making and using the same | |
WO2010070658A3 (en) | Improved process for the preparation of endothelin receptor antagonists | |
WO2012025944A3 (en) | Sitagliptin, salts and polymorphs thereof | |
WO2014057498A3 (en) | Process for the preparation of cobicistat intermediates | |
SG11201406833PA (en) | Catalyst for production of butadiene, process for producing the catalyst, and process for producing butadiene using the catalyst | |
WO2012099381A3 (en) | Preparation method of intermediate of sitagliptin | |
WO2013009585A3 (en) | Systems and methods for product configuration | |
WO2012170793A8 (en) | Biorefinery process for thf production | |
PL2917290T3 (en) | Aqueous dispersions of a multifunctional primary amine, process for its preparation, and use therof | |
WO2013164839A3 (en) | Amorphous form of apixaban, process of preparation and compositions thereof | |
WO2013111163A3 (en) | Process for the preparation of dabigatran etexilate mesylate and polymorphs of intermediates thereof | |
ZA201309199B (en) | Processes and intermediates in the preparation of morphine analogs via n-demethylation of n-oxides using cyclodehydration reagents | |
HK1199242A1 (en) | Process for the production of 1,3-butadiene 13- | |
WO2012168949A3 (en) | A process for preparation of nevirapine | |
WO2014064712A3 (en) | An improved process for the preparation of fulvestrant | |
WO2013092672A3 (en) | Method for recombinant production of labyrinthopeptins and functional derivatives thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12797328 Country of ref document: EP Kind code of ref document: A2 |